Intra-Individual Comparisons of [18F]fluorodeoxyglucose and Prostate-Specific Membrane Antigen Positron Emission Tomography in Prostate Cancer Patients Across Different Disease States: New Insights into Disease Heterogeneity

<b>Background/Objectives:</b> Prostate-specific membrane antigen (PSMA) PET/CT is more accurate than CT and bone scans for staging intermediate and high-risk prostate cancer (PCa). Fluorodeoxyglucose (FDG) PET has improved disease characterisation in metastatic castrate-resistant PCa (mCRPCa) and in...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Stephen McGeorge, David A. Pattison, Nattakorn Dhiantravan, Paul A. Thomas, John W. Yaxley, Matthew J. Roberts
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	MDPI AG 2024-12-01
Schriftenreihe:	Uro
Schlagworte:	PSMA FDG PET prostate cancer CRPC
Online-Zugang:	https://www.mdpi.com/2673-4397/5/1/1
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!